Latest filing published 08 Feb 2019 for Viveve Medical, INC..
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by James G. Atkinson on record concern Viveve Medical, Inc. Between 12 May 2015 and 29 January 2019, the trades on record add up to 13 filings.
Purchases make up the whole of the open-market record (10 purchases, €4.4M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.
Half of the purchases are above €434k and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -6.4%. These figures describe past trades and do not predict future prices.
The record was last updated on 8 February 2019 with a share grant in Viveve Medical, Inc. The clock since the last published purchase (21 March 2017) now reads 3,507 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations